The federal judge presiding over the Zoloft multidistrict litigation has approved a discovery plan that the opposing sides negotiated to set relatively early trial dates while also setting early hearings over the science behind the allegations that women’s use of Zoloft during their pregnancies caused birth defects.
The early trial dates are something that favored the plaintiffs counsel’s position while the issue of relatively early Daubert hearings over the scientific evidence is something that favors the defense counsel’s position.
